Effective Ocd Treatment LLC is categorized under Family Practice Doctors in Denver, CO and active since 2011.
Effective Ocd Treatment LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Matthew Myles at the company’s single location by writing to 2150 West 29th Avenue # 115, Denver, Colorado CO 80211 or by phoning (720) 891-0571. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Effective Ocd Treatment LLC |
| Contact Person: | Matthew Myles |
| Address: | 2150 West 29th Avenue # 115, Denver, Colorado 80211 |
| Phone Number: | (720) 891-0571 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Effective Ocd Treatment LLC was started in 2011 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Matthew Myles for inquiries that concern Effective Ocd Treatment LLC by calling the company number (720) 891-0571, as your correspondence is most welcome. Additionally, the physical location of the single location of Effective Ocd Treatment LLC can be found at the coordinates 39.758288,-105.012988 as well as the street address 2150 West 29th Avenue # 115 in Denver, Colorado 80211.
For its online presence, you may visit Effective Ocd Treatment LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.